Activation of the GABA-alpha receptor by berberine rescues retinal ganglion cells to attenuate experimental diabetic retinopathy

Wangyi Fang(Shanghai Jiao Tong University), Chunhui Jiang(Qingdao University), Kaicheng Wu(Shanghai University), Yuan Zong(Eye & ENT Hospital of Fudan University), Xujiao Zhou(Fudan University), Jian Yu(First Affiliated Hospital of Wenzhou Medical University), Xiaojing Huang(Second Military Medical University), Jiaojiao Wei(Luoyang Normal University), Huan Xu(Central South University), Jiemei Shi(Shanghai Eye Disease Prevention & Treatment Center)
Frontiers in Molecular Neuroscience
August 9, 2022
10.3389/fnmol.2022.930599
Cited by 22

Related Papers

Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
|Nature Biotechnology|2021|186
Therapeutic Nanoparticles from Grape Seed for Modulating Oxidative Stress
|Small|2021|109
Membrane Fusion‐Mediated Loading of Therapeutic siRNA into Exosome for Tissue‐Specific Application
|Advanced Materials|2024|88
Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
|Journal of Neuroscience|2018|78
Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
|Nature Nanotechnology|2025|75